Loading the session
Loading the session
Loading instrument
$67.55
+3.19%Market closedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:29 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +25.3% (SPY −1.6%, XLI −1.2%). 3 months: +8.5% (SPY −0.4%, XLI −9.1%). 1 year: −18.3% (SPY +13.6%, XLI +11.0%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: MMS, SPY and XLI · as of 4 Nov 2026
The 4 Nov 2026 close of $68.51 was 17.3% above its 50-day average ($58.42) and 6.4% above its 200-day average ($64.36). It has closed above the 200-day for 3 sessions, since 2 Nov 2026. The 50-day average crossed below the 200-day on 24 Mar 2026, 156 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
$0.33 a share, payable 30 Nov 2026; unchanged from the previous payment (ex-date 14 Aug 2026).
Corporate actions record · as of 5 Nov 2026
The 14-session relative strength index closed at 74.0 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
Closed at $68.51 on 4 Nov 2026: 31.5% below the 52-week high of $100.00 (23 Jan 2026) and 34.2% above the low of $51.04 (28 Sep 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
February 5, 2026
−16.51%May 8, 2025
+12.78%November 22, 2022
+16.19%